Scarica l'app Stockscreener
36.50
4.79%
1.67
Dopo l'orario di chiusura:
36.69
0.19
+0.52%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché HROW Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$34.83
Aprire:
$35.98
Volume 24 ore:
1.22M
Relative Volume:
2.49
Capitalizzazione di mercato:
$1.34B
Reddito:
$154.15M
Utile/perdita netta:
$-33.58M
Rapporto P/E:
-38.02
EPS:
-0.96
Flusso di cassa netto:
$-20.74M
1 W Prestazione:
+10.54%
1M Prestazione:
+4.49%
6M Prestazione:
+14.38%
1 anno Prestazione:
-3.57%
Intervallo 1D:
$35.34
$37.47
Intervallo di 1 settimana:
$29.75
$38.15
Portata 52W:
$20.85
$59.23
Harrow Inc Stock (HROW) Company Profile
Nome
Harrow Inc
Settore
Telefono
615.733.4731
Indirizzo
1A BURTON HILLS BLVD, NASHVILLE, CA
Confronta HROW con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
HROW
Harrow Inc
|
36.50 | 1.24B | 154.15M | -33.58M | -20.74M | -0.96 |
|
ZTS
Zoetis Inc
|
152.44 | 66.04B | 9.39B | 2.61B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.77 | 45.57B | 29.98B | 958.27M | 5.31B | 0.2964 |
|
HLN
Haleon Plc Adr
|
9.69 | 42.50B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.21 | 18.84B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
309.72 | 13.59B | 2.99B | 1.21B | 1.13B | 25.06 |
Harrow Inc Stock (HROW) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-11 | Iniziato | Cantor Fitzgerald | Overweight |
| 2025-06-12 | Iniziato | BTIG Research | Buy |
| 2025-06-10 | Iniziato | William Blair | Outperform |
| 2025-02-06 | Iniziato | H.C. Wainwright | Buy |
| 2024-12-04 | Reiterato | B. Riley Securities | Buy |
| 2024-04-11 | Iniziato | Craig Hallum | Buy |
| 2022-09-08 | Ripresa | B. Riley Securities | Buy |
| 2021-10-14 | Ripresa | B. Riley Securities | Buy |
| 2021-09-24 | Iniziato | Aegis Capital | Buy |
| 2021-07-02 | Iniziato | Ladenburg Thalmann | Buy |
Mostra tutto
Harrow Inc Borsa (HROW) Ultime notizie
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Harrow, Inc. – HROW - Bluefield Daily Telegraph
Harrow Health, Inc. (NASDAQ:HROW) Q2 2025 Earnings Call Transcript - Insider Monkey
HROW: HC Wainwright & Co. Raises Price Target, Maintains Buy Rat - GuruFocus
Harrow Second Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag - simplywall.st
Harrow: Q2 Earnings Snapshot - Local 3 News
Harrow Inc (HROW) Q2 2025 Earnings Call Highlights: Revenue Surge and Strategic Expansions By GuruFocus - Investing.com Canada
Harrow Health Reports Strong Q2 2025 Financial Results - TipRanks
Harrow, Inc. Q2 2025 Earnings: A Catalyst for Long-Term Ophthalmic Growth - AInvest
Why Harrow Inc. stock attracts strong analyst attentionPowerful ROI Trade Ideas - thegnnews.com
Harrow, Inc. 2025 Q2ResultsEarnings Call Presentation (NASDAQ:HROW) - Seeking Alpha
Earnings call transcript: Harrow Health beats EPS expectations in Q2 2025 - Investing.com UK
Harrow Announces Second-Quarter 2025 Financial Results - GlobeNewswire
Harrow Health’s Growth Streak Sets High Hopes For 2025 - Finimize
Harrow Swings to Q2 Earnings, Revenue Jumps - MarketScreener
Earnings Flash (HROW) Harrow, Inc. Posts Q2 Diluted EPS $0.24 per Share - MarketScreener
Earnings Flash (HROW) Harrow, Inc. Reports Q2 Revenue $63.7M, vs. FactSet Est of $66.0M - MarketScreener
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Harrow, Inc.HROW - WV News
Harrow Inc (HROW) Q2 2025: Everything You Need To Know Ahead Of Earnings - Yahoo Finance
Will Harrow's (HROW) Recent Conference Engagements Reveal More About Its Competitive Position? - simplywall.st
Harrow Inc Q2 2025 Earnings Report Preview: Revenue, Earnings, and Price Targets - AInvest
Harrow 8.625% 20260430 HROWL Q2 2025 Earnings Preview Upside Anticipated on Strong Educational Expansion - AInvest
A Preview Of Harrow's Earnings - 富途牛牛
Harrow, Inc. shares fall 1.82% intraday after announcing participation in H.C. Wainwright’s 5th Annual Ophthalmology Conference. - AInvest
Harrow to Present at H.C. Wainwright 5th Annual Ophthalmology Co - GuruFocus
Harrow to Present at H.C. Wainwright 5th Annual Ophthalmology Conference - The Manila Times
Harrow Executives Reveal Future of Eye Care: Double Feature at Major Ophthalmology Conference - Stock Titan
Insider Backed Growth Companies To Watch Now - simplywall.st
Harrow (HROW) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Yahoo Finance
How volatile is Harrow Inc. stock compared to the marketDiscover the next big stock winners - Jammu Links News
What makes Harrow Inc. stock price move sharplyAchieve breakthrough profits with expert advice - Jammu Links News
Is Harrow Inc. a growth stock or a value stockUncover the best stocks for explosive growth - Jammu Links News
What drives Harrow Inc. stock priceHigh-performance stocks for savvy investors - Jammu Links News
What is the dividend policy of Harrow Inc. stockInvest smarter with comprehensive market analysis - Jammu Links News
What is Harrow Inc. company’s growth strategyBuild wealth faster with expert stock picks - Jammu Links News
While Harrow (NASDAQ:HROW) Shareholders Have Made 432% in 5 Years, Increasing Losses Might Now Be Front of Mind as Stock Sheds 14% This Week - 富途牛牛
Published on: 2025-08-03 17:16:02 - Jammu Links News
What are the latest earnings results for Harrow Inc.Invest confidently with professional guidance - Jammu Links News
What are Harrow Inc. company’s key revenue driversInvest confidently with expert support - Jammu Links News
What analysts say about Harrow Inc. stockDiscover stocks with explosive growth potential - Jammu Links News
What catalysts could drive Harrow Inc. stock higher in 2025Unlock daily stock market insights for success - Jammu Links News
Does Harrow Inc. stock perform well during market downturnsAccess exclusive market insights for free - Jammu Links News
How does Harrow Inc. generate profit in a changing economyDiscover hidden gems in the stock market - Jammu Links News
What is the risk reward ratio of investing in Harrow Inc. stockMaximize returns with timely market signals - Jammu Links News
What are analysts’ price targets for Harrow Inc. in the next 12 monthsUnlock superior stock analysis tools - Jammu Links News
What markets is Harrow Inc. expanding into Is Zedge Inc. stock a good long term investment optionAdvanced Screener Growth Plan For Every Investor - Jammu Links News
When is Harrow Inc. stock expected to show significant growthPre Market Insights For Beginners - Jammu Links News
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Harrow, Inc. – HROW - GlobeNewswire Inc.
Is Harrow Inc. stock overvalued or undervaluedBeginner Investor Ideas For Smart Trading - jammulinksnews.com
Harrow Inc Azioni (HROW) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Harrow Inc Azioni (HROW) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Opaleye Management Inc. | 10% Owner |
Jun 10 '25 |
Sale |
30.80 |
15,000 |
462,033 |
90,000 |
| Opaleye Management Inc. | 10% Owner |
Jun 09 '25 |
Sale |
30.37 |
15,204 |
461,794 |
105,000 |
| Opaleye Management Inc. | 10% Owner |
Jun 03 '25 |
Sale |
30.04 |
3,000 |
90,116 |
122,000 |
| Opaleye Management Inc. | 10% Owner |
Jun 04 '25 |
Sale |
30.02 |
1,796 |
53,907 |
120,204 |
| Opaleye Management Inc. | 10% Owner |
May 12 '25 |
Sale |
25.90 |
10,000 |
258,959 |
130,000 |
| Opaleye Management Inc. | 10% Owner |
May 13 '25 |
Sale |
26.59 |
5,000 |
132,945 |
125,000 |
| BOLL ANDREW R. | Chief Financial Officer |
Apr 03 '25 |
Option Exercise |
0.00 |
346,500 |
0 |
914,589 |
| SAHAREK JOHN P. | CEO & President, ImprimisRx |
Apr 03 '25 |
Option Exercise |
0.00 |
277,200 |
0 |
576,863 |
| BAUM MARK L | Chief Executive Officer |
Apr 03 '25 |
Option Exercise |
0.00 |
762,300 |
0 |
2,899,825 |
| Opaleye Management Inc. | 10% Owner |
Mar 18 '25 |
Sale |
30.01 |
5,000 |
150,055 |
140,000 |
4.37%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):